Impact of Online Patient Feedback (OQ) to Therapist | NCT01891045

Studies
Impact of Online Patient Feedback (OQ) to Therapist

NCT01891045

Sponsor

Oslo University Hospital

Status

Completed

Last Update Posted

Jan 24, 2024Actual

Enrollment

160Actual

Phase

Not Applicable

Conditions

Drug Addiction
Drug Abuse

Interventions

OQ-45.2 no feedback
OQ-45.2

Countries

Norway

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2024

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jul 1, 2011

Primary Completion Date

Nov 1, 2014Actual

Completion Date

Jan 3, 2023Actual

First Submitted Date

Jul 6, 2012

First Submission Date that Met QC Criteria

Jun 27, 2013

First Posted Date

Jul 2, 2013Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 23, 2024

Last Update Posted Date

Jan 24, 2024Actual

Name	Class
University of Oslo	OTHER

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Dropout represents one of the largest problems in substance abuse treatment. International and Nordic research show that only 20 - 40 % of substance abusers complete treatment as intended. At the same time, one of the most consistent factors of favourable post-treatment outcome is treatment completion. In spite of the serious and continuous challenge dropout represents the phenomena is not well understood and there is a need to explore more of the factors that influence dropout and how it can be counteracted. As also stated: "…effective methods for reducing the problem of dropouts from treatment is one more area in need of further research" (NOU 2003:4, s 77).

For the general field of mental health one of the most important innovations involves providing therapists with patient feedback about their progress. The most well-established and widely researched feedback system is the Outcome Questionnaire (OQ-45.2). The system has been shown to improve treatment outcomes, including reduced treatment dropout and length of treatment, but the system is yet to be utilized with a substance abusing patient group. The aim of the present study is to examine the usefulness of OQ-45.2 with substance abusing patients.

Detailed Description

Hypotheses and research questions

1. The OQ-45.2 feedback will be effective in identifying patients at risk of dropout of substance abuse treatment.

1a. The condition were feedback is withheld from the therapist, will correctly identify patients who will dropout.

Research Question: Is there variation in the accuracy of dropout prediction as a function of age, gender differences or type of substance abuse?

2. The OQ-45.2 feedback will be effective in reducing dropout in outpatient substance abuse treatment.

2a. The feedback condition will result in less dropout than the no-feedback condition.

Research Question: Is there a variation in the OQ-45.2 preventive dropout effect due to age, gender or type of substance abuse?

3. The OQ-45.2 feedback will shorten length of inpatient substance abuse treatment.

3a. The feedback condition will identify patients who are ready to terminate therapy.

Research Question: Is there variation in identification of patients ready to terminate as a function of age, gender differences or type of substance abuse?

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

160Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Control	No Intervention	Patients merely monitored on background variables to function as a baseline of comparison
Prediction	Active Comparator	Patients randomized to this condition completes the OQ-45.2 weekly, but the reports are withheld from therapists and patients.	Behavioral: OQ-45.2 no feedback
Intervention	Experimental	Patients and therapists uses the feedback-system as intended, with real-time feedback to the therapist and full use of the suggested interventions	Behavioral: OQ-45.2

Interventions

Name	Type	Description	Arm Group Labels	Other Names
OQ-45.2 no feedback	Behavioral	Completion of the OQ-45.2 before each session, but no feedback to therapists or patients	Prediction

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Drop-out from residential SUD treatment	Exit reason from residential Substance Use Disorder treatment (Drop-out or completed as planned)	Four years

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Primary diagnosis of addiction, F10-19, using the International Classification of Diseases, admitted in 2011-2014 for treatment at the department of addiction treatment - youth, Oslo University Hospital

Exclusion Criteria:

Ongoing psychoses, severe language difficulties

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

16 Years

Maximum Age

26 Years

Standard Ages

ChildAdult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Department of addiction treatment- youth		Oslo		0514	Norway
Oslo University Hospital - Department of addiction treatment youth

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
24188797	Result	Amble I, Gude T, Stubdal S, Oktedalen T, Skjorten AM, Andersen BJ, Solbakken OA, Brorson HH, Arnevik E, Lambert MJ, Wampold BE. Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context. Psychother Res. 2014;24(4):504-13. doi: 10.1080/10503307.2013.849016. Epub 2013 Nov 5.
31452601

ID	Term
D064419	Chemically-Induced Disorders
D001523	Mental Disorders